Studies Find B7-H3 Protein a Novel, Promising Target for Prostate Cancer Treatments

The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by

Related Keywords

Eugene Shenderov ,Johns Hopkins ,Johns Hopkins University ,Lifeimmune Inc ,Johns Hopkins Kimmel Cancer Center ,Prostate Cancer Foundation ,European Society For Medical Oncology ,Johns Hopkins Kimmel Cancer ,European Society ,Medical Oncology ,Conquer Cancer ,Defense Congressionally Directed Medical Research ,Newswise ,Ohns Hopkins Kimmel Cancer Center Prostate Eugene Shenderov B7 H3 Immunotheraphy Esmo ,Cancer ,Womens Health ,Pharmaceuticals ,Medical Meetings ,Johns Hopkins Medicine ,